A Call to Limit Antibiotic Use in Acne
December 2013 | Volume 12 | Issue 12 | Editorials | 1331 | Copyright © December 2013
Diane Thiboutot MD,a Brigitte Dreno MD PhD,b Harald Gollnick MD,c Vincenzo Bettoli MD,d Sewon Kang MD,e James J. Leyden MD,f Alan Shalita MD,g and Vicente Torres MDh for the Global Alliance to Improve Outcomes in Acne
aDepartment of Dermatology, Penn State University College of Medicine, Hershey, PA
bDepartment of Dermato-Cancerology, University of Nantes, France
cDepartment of Dermatology and Venereology Medical Faculty, Otto-Von- Guericke-Universitat, Magdeburg, Germany
dDepartment of Clinical and Experimental Medicine, Section of Dermatology, Azienda Ospedaliera University of Ferrara, Italy
eDepartment of Dermatology, Johns Hopkins Medicine, Baltimore, MD
fDepartment of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA
gDepartment of Dermatology, State University of New York Downstate Medical Center, Brooklyn, NY
hDepartment of Dermatology, Juarez Hospital, Mexico City, Mexico
Many may be less familiar with the fact that there is significant antibiotic use in acne with patients often taking prolonged courses of antibiotic therapy. Acne affects the vast majority of the world’s population at some time in their lives, and many clinicians who manage acne patients utilize antibiotics as a primary treatment. As dermatologists with special interest in acne, we call on our colleagues in medicine to review current information on antibiotic use in acne and prescribe these agents in a judicial manner. We discuss below some of the primary reasons to revise the current prescription pattern.
Visit the acne resource center.